17a-OH Progesterone

Plasma/Serum concentrations of 17α-hydroxyprogesterone (17-OHP) are valuable in the initial diagnosis of congenital adrenal hyperplasia (CAH).  The common inborn error of metabolism is usually characterized by deficiency in the C21-hydroxylase enzyme system and necessitates steroid replacement therapy. The effectiveness of treatment has been monitored by determining circulating 17-OHP concentrations.

The Biorex Diagnostics 17a-OH Progesterone kit is intended for the Quantitative Determination of 17α-OH Progesterone Concentration in Human Serum or Plasma by a Microplate Enzyme Immunoassay, Colorimetric.